Graham Capital Management, L.P.
Position in PRLD — Prelude Therapeutics Inc
CIK 1315421
ROWAYTON, CT
Position in PRLD
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$38,793
New position
Shares Held
11,343
first reported quarter
Ownership
0.014%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Mar 31, 2026Graham Capital Management, L.P. holds $14,869,409 across 66 Biotechnology names. PRLD ranks #62 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JAZZ |
Jazz Pharmaceuticals plc
|
4,606 | $870,764 | |
| 2 | TECH |
BIO-TECHNE Corp
|
9,949 | $519,934 | |
| 3 | SRPT |
Sarepta Therapeutics, Inc.
|
22,442 | $488,337 | |
| 4 | BHVN |
Biohaven Ltd.
|
55,399 | $468,675 | |
| 5 | NUVL |
Nuvalent, Inc.
|
4,112 | $421,274 | |
| 6 | ADMA |
Adma Biologics, Inc.
|
45,222 | $407,450 | |
| 7 | MNKD |
Mannkind Corp
|
161,189 | $394,913 | |
| 8 | ABCL |
AbCellera Biologics Inc.
|
112,831 | $393,780 |
All Filings in PRLD
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $38,793 | 11,343 | Shares | Sole | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||